AGER and metabolic syndrome: The reduced sRAGE levels observed in obesity, IR, metabolic syndrome, and CVD could be due to the upregulation of membrane RAGE expression, the reduced RAGE cleavage, and the downregulation of esRAGE expression and secretion [88,89,90,91].